200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 84680-54-6

84680-54-6

84680-54-6 | Enalaprilat dihydrate

CAS No: 84680-54-6 Catalog No: AG003PXC MDL No:MFCD00941393

Product Description

Catalog Number:
AG003PXC
Chemical Name:
Enalaprilat dihydrate
CAS Number:
84680-54-6
Molecular Formula:
C18H28N2O7
Molecular Weight:
384.4241
MDL Number:
MFCD00941393
SMILES:
OC(=O)[C@@H](N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C)CCc1ccccc1.O.O

Literature

Title Journal
Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines. Toxicology and applied pharmacology 20140201
Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy. European journal of pharmacology 20130815
An in vitro reconstitution system to address the mechanism of the vascular expression of the bradykinin B₁ receptor in response to angiotensin converting enzyme inhibition. Vascular pharmacology 20120819
Quantitative determination of lisinopril in human plasma by high performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. Biomedical chromatography : BMC 20120601
Determination of enalapril and enalaprilat in small human serum quantities for pediatric trials by HPLC-tandem mass spectrometry. Biomedical chromatography : BMC 20120601
Inhibition of ACE activity contributes to the intestinal structural compensation in a massive intestinal resection rat model. Pediatric surgery international 20120501
The pharmacological mechanism of angiotensin-converting enzyme inhibition by green tea, Rooibos and enalaprilat - a study on enzyme kinetics. Phytotherapy research : PTR 20120401
Inhibitory effects of enalaprilat on rat cardiac fibroblast proliferation via ROS/P38MAPK/TGF-β1 signaling pathway. Molecules (Basel, Switzerland) 20120306
Rapid and sensitive liquid chromatography/tandem mass spectrometry method for simultaneous determination of enalapril and its major metabolite enalaprilat, in human plasma: application to a bioequivalence study. Drug testing and analysis 20120201
Myocardial autophagy after severe burn in rats. PloS one 20120101
Modulation of nitric oxide affects myocardial perfusion-contraction matching in anaesthetized dogs with recurrent no-flow ischaemia. Experimental physiology 20111201
Insignificant response of the fetal placental circulation to arterial hypotension in sheep. Journal of applied physiology (Bethesda, Md. : 1985) 20111001
Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis. American journal of physiology. Renal physiology 20111001
Acute effects of the ACE inhibitor enalaprilat on the pulmonary, cerebral and systemic blood flow and resistance after the bidirectional cavopulmonary connection. Heart (British Cardiac Society) 20110801
Sublingual microcirculatory effects of enalaprilat in an ovine model of septic shock. Shock (Augusta, Ga.) 20110601
What's new in Shock, June 2011? Shock (Augusta, Ga.) 20110601
Gadolinium increases the vascular reactivity of rat aortic rings. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110501
A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase. Journal of cellular and molecular medicine 20110201
Enalaprilat-mediated activation of kinin b(1) receptors and vasodilation in the rat isolated perfused kidney. Pharmacology 20110101
A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells. Peptides 20100801
Reduced systolic pressure load decreases cell-cycle activity in the fetal sheep heart. American journal of physiology. Regulatory, integrative and comparative physiology 20100801
Enalaprilat and enalapril maleate eyedrops lower intraocular pressure in rabbits. Acta ophthalmologica 20100501
Attenuation of renal excretory responses to ANG II during inhibition of superoxide dismutase in anesthetized rats. American journal of physiology. Renal physiology 20100201
Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade. Hypertension (Dallas, Tex. : 1979) 20100201
A high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method using solid phase extraction for the simultaneous determination of plasma concentrations of enalapril and enalaprilate in hypertensive patients treated with different pharmaceutical formulations. Therapeutic drug monitoring 20091201
Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme. The Journal of biological chemistry 20091113
[Influence of the angiotensin converting enzyme inhibition on the functional proteinuria in rats]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20091001
Early effects of high glucose in retinal tissue cultures Renin-Angiotensin system-dependent and -independent signaling. Neurobiology of disease 20090801
[Effects of angiotensin (1-7) and enalaprilat on function of isolated rat heart perfused by burn serum]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 20090601
Nanocomposites coated with xyloglucan for drug delivery: In vitro studies. International journal of pharmaceutics 20090209
Effect of hypotensive challenge on systemic hemodynamics and cerebral blood flow in persons with tetraplegia. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20090201
Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. Journal of pharmaceutical and biomedical analysis 20090115
[The use of parenteral enalaprilat for the treatment of patients with hypertensive crisis and incipient acute disturbance of cerebral circulation]. Kardiologiia 20090101
Myocardial protection with enalaprilat in patients unresponsive to ischemic preconditioning during percutaneous coronary intervention. Canadian journal of physiology and pharmacology 20081201
[Effects of single or combined administration of cedilanid and enalaprilat on visceral damages in early stage of severe scald in rats]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 20081201
Protective effect of captopril and enalaprilat, angiotensin-converting enzyme inhibitors, on para-nonylphenol-induced *OH generation and dopamine efflux in rat striatum. Toxicology 20080904
Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment. Surgery 20080801
[Protective effect of enalaprilat injection against early postburn organ damage in rats]. Zhonghua wai ke za zhi [Chinese journal of surgery] 20080701
Perioperative hypertension management. Vascular health and risk management 20080601
[Protective effects of enalaprilat on the myocardial kinetics in rats at early stage of severe scald]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 20080601
Lack of direct interaction between enalaprilat and the kinin B1 receptors. Peptides 20080401
17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women. Hypertension (Dallas, Tex. : 1979) 20080401
Low nanomolar concentration of mercury chloride increases vascular reactivity to phenylephrine and local angiotensin production in rats. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20080301
Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats. Hypertension (Dallas, Tex. : 1979) 20080201
Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension (Dallas, Tex. : 1979) 20080201
Expression of angiotensin I-converting enzymes and bradykinin B2 receptors in mouse inner medullary-collecting duct cells. International immunopharmacology 20080201
Enalaprilat induced acute parotitis. The Journal of the Association of Physicians of India 20080201
Angiotensin blockade and matrix synthesis by glomerular epithelial cells in high glucose: a further experimental insight into the pathophysiology of diabetic nephropathy. La Clinica terapeutica 20080101
[The in vitro cross-effects of inhibitors of renin-angiotensin and fibrinolytic systems on the key enzymes of these systems]. Bioorganicheskaia khimiia 20080101
Effects of enalaprilat on acute necrotizing pancreatitis in rats. Inflammation 20071201
Structural characterization of photodegradation products of enalapril and its metabolite enalaprilat obtained under simulated environmental conditions by hybrid quadrupole-linear ion trap-MS and quadrupole-time-of-flight-MS. Analytical chemistry 20071101
Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril. Journal of cardiovascular pharmacology 20070801
Effects of intracoronary low-dose enalaprilat on ventricular repolarization dynamics after direct percutaneous intervention for acute myocardial infarction. Pacing and clinical electrophysiology : PACE 20070501
Effect of enalapril on the in vitro and in vivo peptidyl cleavage of a potent VLA-4 antagonist. Xenobiotica; the fate of foreign compounds in biological systems 20070501
Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. Journal of the American College of Cardiology 20070417
Pharmacokinetics and pharmacodynamics of a nitric oxide-releasing derivative of enalapril in male beagles. Clinical and experimental pharmacology & physiology 20070401
Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Digestive diseases and sciences 20070401
Intracoronary enalaprilat during angioplasty for acute myocardial infarction: alleviation of postischaemic neurohumoral and inflammatory stress? Journal of internal medicine 20070201
Effects of 4 classes of cardiovascular drugs on ventricular function in dogs with mitral regurgitation. Journal of veterinary internal medicine 20070101
Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I. Canadian journal of physiology and pharmacology 20061101
Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system. Acta physiologica (Oxford, England) 20061001
Systemic and regional hemodynamic effects of enalaprilat infusion in experimental normotensive sepsis. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20060901
The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels. Pharmacy world & science : PWS 20060601
Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats. British journal of anaesthesia 20060401
The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. European journal of endocrinology 20060201
On call. I reread your articles on congestive heart failure when I was diagnosed with the condition last month. My breathing is back to normal, and I feel well. My doctor has prescribed all the medications you recommended, but he disagreed with one. He said that since I'm taking Vasotec, I should stop my aspirin. Do you agree? Harvard men's health watch 20060201
Assessment of drug-induced QT interval prolongation in conscious rabbits. Journal of pharmacological and toxicological methods 20060101
Interference of enalaprilat on glomerular permeability to macromolecules (IgG) in acute unilateral ureteral obstruction in rats. International braz j urol : official journal of the Brazilian Society of Urology 20060101
Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men. Arteriosclerosis, thrombosis, and vascular biology 20051101
Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. American journal of physiology. Renal physiology 20051001
Effects of enalaprilat on the renin-angiotensin-aldosterone system and on renal function during CO2 pneumoperitoneum. Journal of endourology 20051001
Human vagal baroreflex sensitivity fluctuates widely and rhythmically at very low frequencies. The Journal of physiology 20050915
Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays. Journal of clinical pharmacy and therapeutics 20050801
The sensitivity of the cis/trans-isomerization of enalapril and enalaprilat to solvent conditions. The Journal of pharmacy and pharmacology 20050701
Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR. Regulatory peptides 20050415
Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial. European journal of clinical pharmacology 20050401
High-performance liquid chromatographic determination of enalapril in human plasma by enzyme kinetic analytical method. Journal of pharmaceutical and biomedical analysis 20050401
Partial angiotensin-converting enzyme inhibition during acute orthostatic stress in persons with tetraplegia. The journal of spinal cord medicine 20050101
Simultaneous determination of enalapril and enalaprilat in human plasma by liquid chromatography-tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225
Effects of enalaprilat infusion on hemodynamics and renal function in patients undergoing cardiac surgery. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20041201
Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. American journal of physiology. Heart and circulatory physiology 20041101
Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. American journal of physiology. Renal physiology 20041101
Predominant postglomerular vascular resistance response to reflex renal sympathetic nerve activation during ANG II clamp in rabbits. American journal of physiology. Regulatory, integrative and comparative physiology 20041001
A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme. Biophysical chemistry 20041001
Intracellular and extracellular angiotensin II enhance the L-type calcium current in the failing heart. Hypertension (Dallas, Tex. : 1979) 20040901
Ouabain at nanomolar concentration promotes synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats. Journal of cardiovascular pharmacology 20040901
Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 20040713
Role of brain and peripheral angiotensin II in hypertension and altered arterial baroreflex programmed during fetal life in rat. Pediatric research 20040601
Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. Journal of cardiovascular pharmacology 20040501
Losartan but not enalaprilat acutely reduces reperfusion ventricular tachyarrhythmias in hypertrophied rat hearts after low-flow ischaemia. The Journal of pharmacy and pharmacology 20040401
Experimental design optimization of a capillary zone electrophoresis method for the screening of several diuretics and ACE inhibitors. Journal of chromatographic science 20040201
Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. Journal of the American Society of Nephrology : JASN 20040101
Determination of the cis-trans isomerization barrier of enalaprilat by dynamic capillary electrophoresis and computer simulation. Electrophoresis 20040101
Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses. Journal of veterinary internal medicine 20040101
Evaluation of the efficacy, safety and tolerability of intravenous enalaprilat in the treatment of grade III essential hypertension in Indian patients. Indian heart journal 20040101
Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs. Critical care (London, England) 20040101
Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts. Journal of cardiovascular pharmacology and therapeutics 20031201
Omapatrilat increases renal endothelin in deoxycorticosterone acetate-salt hypertensive rats. Vascular pharmacology 20031201
A novel activation process of protein kinase C in the remote, non-ischemic area of an infarcted heart is mediated by angiotensin-AT1 receptors. Journal of molecular and cellular cardiology 20031101
Relative bioavailability study of 20-mg enalapril tablets in healthy male volunteers. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20031001
NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. American journal of physiology. Heart and circulatory physiology 20030901
Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II. Regulatory peptides 20030815
Differentiation between acute cyclosporine nephrotoxicity and acute tubular necrosis using enalaprilat renal scintigraphy in rats. Investigative radiology 20030801
Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor? American journal of physiology. Heart and circulatory physiology 20030701
Regional norepinephrine spillover in response to angiotensin-converting enzyme inhibition in healthy subjects. Journal of hypertension 20030701
Effects of enalaprilat on venoconstriction to norepinephrine: role of prostaglandins. Cardiovascular research 20030701
Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20030701
Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries. The Journal of physiology 20030501
Enalaprilat, losartan and LU 135252 in coronary blood flow regulation. European journal of clinical investigation 20030501
Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Critical care medicine 20030501
Is there an 'ACE' in the hole for postcoronary artery bypass graft myocardial dysfunction? Critical care medicine 20030501
Bioequivalence study of two brands of enalapril tablets after single oral administration to healthy volunteers. International journal of clinical pharmacology and therapeutics 20030501
RP-HPLC and NMR study of cis-trans isomerization of enalaprilat. Journal of pharmaceutical and biomedical analysis 20030326
Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans. Hypertension (Dallas, Tex. : 1979) 20030301
Role of angiotensin II in the neural control of renal function. Hypertension (Dallas, Tex. : 1979) 20030301
Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Circulation 20030204
Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. American heart journal 20030201
Simultaneous quantitation of enalapril and enalaprilat in human plasma by 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry. Rapid communications in mass spectrometry : RCM 20030101
Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action. Nephron. Physiology 20030101
Effects of an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitors on burst forming units-erythroid in chronic hemodialysis patients. American journal of nephrology 20030101
Captopril and enalaprilat decrease antioxidant defences in human endothelial cells and are unable to protect against apoptosis. Cell biology international 20030101
Angiotensin-converting enzyme inhibition modulates high-glucose-induced extracellular matrix changes in mouse glomerular epithelial cells. Nephron. Experimental nephrology 20030101
Prejunctional AT(1) receptor subtype-dependent modification of neurotransmitter releases in canine isolated splenic arteries. Autonomic & autacoid pharmacology 20030101
Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation. Journal of the American College of Cardiology 20021106
Angiotensin II contributes to arterial compliance in congestive heart failure. American journal of physiology. Heart and circulatory physiology 20021001
Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig. British journal of anaesthesia 20021001
Captopril and quinapril reduce reactive oxygen species. European journal of clinical investigation 20021001
Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. Journal of the American Society of Nephrology : JASN 20020901
Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy. Basic research in cardiology 20020901
Impaired regulation of renal oxygen consumption in spontaneously hypertensive rats. Journal of the American Society of Nephrology : JASN 20020701
Icatibant blocks but does not reverse ACE inhibitor renal effect in Goldblatt rabbit. Clinical and experimental hypertension (New York, N.Y. : 1993) 20020701
Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation 20020611
Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. International journal of pharmaceutics 20020604
Renal nerve stimulation augments effect of intraluminal angiotensin II on proximal tubule transport. American journal of physiology. Renal physiology 20020601
Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach. Stroke 20020601
Determination of enalapril and enalaprilat by enzyme linked immunosorbent assays: application to pharmacokinetic and pharmacodynamic analysis. Fundamental & clinical pharmacology 20020601
Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. The Journal of biological chemistry 20020510
AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. American journal of physiology. Heart and circulatory physiology 20020401
Enalaprilat improves systemic cardiovascular parameters and mesenteric blood flow during hypotensive resuscitation from hemorrhagic shock in dogs. Shock (Augusta, Ga.) 20020301
Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin. Canadian journal of physiology and pharmacology 20020201
Effect of angiotensin-converting enzyme inhibitors on liver regeneration in rats. Hepato-gastroenterology 20020101
Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. The American journal of cardiology 20011215
High serum enalaprilat in chronic renal failure. Journal of the renin-angiotensin-aldosterone system : JRAAS 20011201
Enalaprilat blunts reflexive increases in cardiac interstitial norepinephrine in conscious rats. Journal of hypertension 20011101
The pharmacokinetics of enalapril in children and infants with hypertension. Journal of clinical pharmacology 20011001
Inhibition of serum angiotensin-converting enzyme in rabbits after intravenous administration of enalaprilat-loaded intact erythrocytes. The Journal of pharmacy and pharmacology 20010901
Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing. The Journal of pharmacology and experimental therapeutics 20010801
Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy. Journal of the American College of Cardiology 20010801
High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size. The Annals of thoracic surgery 20010801
Effects of enalaprilat on cardiorespiratory, hemodynamic, and hematologic variables in exercising horses. American journal of veterinary research 20010701
Effect of column temperature on the behaviour of some angiotensin converting enzyme inhibitors during high-performance liquid chromatographic analysis. Journal of chromatography. B, Biomedical sciences and applications 20010505
The bladder angiotensin system in female rats: response to infusions of angiotensin I and the angiotensin converting enzyme inhibitor enalaprilat. The Journal of urology 20010501
Influence of Ca(2+)-activated K(+) channels on rat renal arteriolar responses to depolarizing agonists. American journal of physiology. Renal physiology 20010401
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Journal of the American College of Cardiology 20010315
The renal nerve is required for regulation of proximal tubule transport by intraluminally produced ANG II. American journal of physiology. Renal physiology 20010301
The pancreatic islets in spontaneously hypertensive rats: islet blood flow and insulin production. European journal of endocrinology 20010201
Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II. Hypertension (Dallas, Tex. : 1979) 20010201
A simple HPLC method for quantitation of enalaprilat. Journal of pharmaceutical and biomedical analysis 20010201
Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. British journal of anaesthesia 20010201
Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine. Pediatric nephrology (Berlin, Germany) 20010101
Effects of digoxin, furosemide, enalaprilat and metoprolol on endothelial function in young normotensive subjects. Clinical and experimental pharmacology & physiology 20010101
Enalaprilat attenuates ischemic rises in intracellular sodium in the isolated rat heart via the bradykinin receptor. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20010101
Comparative study of effects of angiotensin II receptor antagonist, KD3-671, and angiotensin converting enzyme inhibitor, enalaprilat, on cough reflex in guinea pig. European journal of drug metabolism and pharmacokinetics 20010101
In vitro characterization of human intact erythrocytes loaded by enalaprilat. Drug delivery 20010101
Effects of indomethacin on hemodynamic parameters after intravenous administration of propranolol and enalaprilat in rabbits. Polish journal of pharmacology 20010101
A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. Anesthesia and analgesia 20001001
Protective effect of imidaprilat, an angiotensin-converting enzyme inhibitor on *OH generation in rat myocardium. Biochimica et biophysica acta 19991018
Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat. Hypertension (Dallas, Tex. : 1979) 19970801
[Enalaprilat in the prevention of left ventricular hypertrophy induced by isoproterenol]. Arquivos brasileiros de cardiologia 19970701
[Effect of enalaprilat on cardiotoxicity induced by doxorubicin]. Arquivos brasileiros de cardiologia 19961001
Endogenous vasopressin and renin-angiotensin systems support blood pressure after epidural block in humans. Anesthesiology 19940501
Replacement of L-Lys by D-Lys(NH2) in peptide Ala-Arg-Pro-Ala-Lys (peptide 6A) increases its coronary blood flow-promoting properties. Journal of cardiovascular pharmacology 19940101
Compared properties of trandolapril, enalapril, and their diacid metabolites. Journal of cardiovascular pharmacology 19940101
No relation of the suppressive effect on the sympathetic nervous system to the acute hypotension caused by imidapril and enalapril. Japanese journal of pharmacology 19931101
Influence of converting enzyme inhibition on isoflurane-induced hypotension for cerebral aneurysm surgery. Anaesthesia 19920301
Microvascular effects of cocaine; interaction with nitrendipine and enalaprilat. Journal of toxicology. Clinical toxicology 19910101
Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines. Journal of medicinal chemistry 19880601
The acute haemodynamic effects of intravenous enalaprilic acid (MK422) in patients with left ventricular dysfunction. British journal of clinical pharmacology 19870101
Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation. Journal of cardiovascular pharmacology 19860101
Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain. Molecular pharmacology 19851201
Proteolytic conversion of [Met]enkephalin-Arg6-Gly7-Leu8 by brain synaptic membranes. Characterization of formed peptides and mechanism of proteolysis. The Journal of biological chemistry 19850310
An overview of the clinical pharmacology of enalapril. British journal of clinical pharmacology 19840101
Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man. Drug metabolism reviews 19830101

© 2019 Angene International Limited. All rights Reserved.